Skip to main content

Want a detailed portfolio tracker?

Lexicon Pharmaceuticals (LXRX) P/E (2018 - 2026)

Lexicon Pharmaceuticals (LXRX) P/E from Oct 1, 2018 to Jul 20, 2026. The TTM Lexicon Pharmaceuticals (LXRX) P/E is -32.88. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Lexicon Pharmaceuticals (LXRX)

YearP/EChange
2026-32.88+295.34%
2025-8.32+622.43%
2024-1.15-45.20%
2023-2.10-32.45%
2022-3.11-126.83%
202111.59+451.40%
20202.10-26.78%
20192.87-111.23%
2018-25.56N/A

Comparison Lexicon Pharmaceuticals (LXRX) P/E with competitors

Lexicon Pharmaceuticals (LXRX) P/E is -32.88.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.01%
ENLVEnlivex Ltd0.07-100.23%
FGENFibroGen Inc0.24-100.73%
CHRSCoherus Biosciences Inc0.85-102.58%
FBIOFortress Biotech Inc0.95-102.89%
ORMPOramed Pharmaceuticals Inc1.50-104.57%
AGENAgenus Inc3.01-109.15%
INVAInnoviva Inc3.15-109.59%
VXRTVaxart Inc3.55-110.79%
CRMDCorMedix Inc3.63-111.03%
CVACCureVac N.V.4.45-113.52%
GLPGGalapagos NV4.86-114.78%
SRPTSarepta Therapeutics Inc4.88-114.85%
ABEOAbeona Therapeutics Inc5.39-116.38%
ABUSArbutus Biopharma Corp5.60-117.02%
ZVRAZevra Therapeutics Inc5.89-117.90%
SPROSpero Therapeutics Inc6.23-118.94%
CGENCompugen Ltd6.31-119.20%
RIGLRigel Pharmaceuticals6.87-120.90%
SLXNSilexion Therapeutics Corp7.30-122.19%
OMEROmeros Corporation9.26-128.16%
AUPHAurinia Pharmaceuticals Inc9.58-129.15%
PLXProtalix BioTherapeutics Inc10.89-133.12%
ACADAcadia Pharmaceuticals Inc11.73-135.67%
TBPHTheravance Biopharma Inc12.26-137.29%
ADMAAdma Biologics Inc12.42-137.76%
HRMYHarmony Biosciences Holdings Inc13.82-142.03%
SABSSAB Biotherapeutics Inc14.14-142.99%
NAGENiagen Bioscience Inc14.82-145.06%
INCYIncyte Corp15.82-148.12%
REGNRegeneron Pharmaceuticals Inc15.86-148.22%
PBYIPuma Biotechnology Inc17.32-152.66%
CPRXCatalyst Pharmaceuticals Inc17.44-153.03%
EXELExelixis Inc17.54-153.33%
TGTXTG Therapeutics Inc18.97-157.68%
MDXGMimedx Group Inc20.55-162.50%
XOMAXOMA Royalty Corp22.87-169.56%
ARGXArgen X SE24.30-173.89%
CTMXCytomX Therapeutics Inc24.82-175.48%
XOMAOXOMA Royalty Corp25.34-177.08%
HALOHalozyme Therapeutics Inc25.62-177.92%
XOMAPXOMA Royalty Corp25.67-178.07%
VRTXVertex Pharmaceuticals Inc27.99-185.13%
RPRXRoyalty Pharma plc - Class A28.69-187.24%
SLNOSoleno Therapeutics Inc29.02-188.24%
ASNDAscendis Pharma A/S30.09-191.49%
LGNDLigand Pharmaceuticals Inc - Class B37.91-215.29%
APLSApellis Pharmaceuticals Inc39.02-218.67%
BMRNBiomarin Pharmaceutical Inc42.21-228.37%
KRYSKrystal Biotech Inc45.34-237.89%
ONCBeiGene Ltd69.54-311.48%
PHARPharming Group N.V.75.03-328.16%
TECHBio-Techne Corp101.96-410.06%
VCELVericel Corp109.92-434.28%
ALNYAlnylam Pharmaceuticals Inc117.96-458.74%
GMABGenmab140.29-526.64%
TLXTelix Pharmaceuticals Ltd162.15-593.12%
CORTCorcept Therapeutics Inc212.86-747.32%